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Introduction
Despite significant improvements in antenatal care, the rate 
of stillbirth deliveries has remained static in the United 
Kingdom, at approximately 5 per 1000 births,1 over the past 
two decades. In a meta-analysis published in 2011, the risk of 
stillbirth in high-income countries was demonstrated to be 
four times higher in fetuses measuring small-for-gestational 
(SGA) age compared with non-SGA fetuses, and SGA was 
noted to have the greatest population-attributable risk com-
pared to other risks of stillbirth.2,3 Furthermore, a retrospec-
tive population study has shown that the antenatal detection 
of SGA could potentially halve the risk of stillbirth.4,5 
Therefore, improving the identification and monitoring of 
the SGA fetus could prevent stillbirth, likely through appro-
priate antenatal surveillance and timely delivery.2,6
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There is no consensus as to the optimal timing of deliv-
ery in pregnancies complicated by SGA. Clinicians have 
to balance the risks of premature delivery, with the risk of 
stillbirth or survival, with the consequences of in-utero 
oxygen and nutrient deprivation. Given the impact of 
global stillbirth, it is important to identify antenatal fetal 
surveillance tests that optimize the timing of delivery for 
pregnancy complicated by SGA fetus, in order to prevent 
stillbirth.2
Current techniques for fetal surveillance employ differ-
ent criteria for determining the timing of delivery but have 
made little impact on stillbirth rates7 because of their limi-
tations. Ultrasound scans (for fetal biometry, quantification 
of amniotic fluid and Doppler assessments) and electronic 
fetal heart rate (FHR) monitoring by cardiotocography 
(CTG) are the most common investigations routinely per-
formed for monitoring SGA fetuses.4,7,8 However, both 
techniques only provide a snap-shot of information on fetal 
well-being at regular intervals.9 They also restrict patient 
mobility and cannot be employed over long-time peri-
ods.10,11 It is plausible that newer ambulatory techniques 
that enable monitoring over a longer time period such as 
fetal electrocardiogram (ECG)–monitoring devices10 may 
improve the prediction of the risk of stillbirth and better 
inform decisions about the timing of delivery for women 
carrying SGA fetuses.
Although, previous studies have investigated the 
acceptability and feasibility of transabdominal fetal ECG 
monitoring during pregnancy and labor in the home and 
hospital environment, none of these studies recruited 
women to wear the monitor more than once.10,12–16 This 
study was therefore aimed to explore the acceptability of 
wearing the portable fetal ECG monitor on more than one 
occasion at different stages of pregnancy in the home envi-
ronment using self-completed questionnaires followed by 
focus group discussion to allow in-depth exploration of the 
important issues raised from the woman’s perspective.
Methods
Recruitment
The prospective cohort study was conducted at Jessop 
Wing Hospital, Sheffield and approved by the North-West 
Preston NRES Research Ethics committee (15/NW/0278). 
The study group consisted of 35 non-laboring women with 
singleton pregnancies between 24 and 40 weeks gestation 
and an estimated fetal weight (EFW) of less than the 10th 
gestational centile on ultrasound scan.17 Patients with any 
fetal malformations were excluded from the study.
Informed written consent was obtained, and the fetal 
ECG monitor (Monica AN24; see Figure 1) was fitted by 
placing five skin electrodes in a standardized position on 
the maternal abdomen.10 When fully charged, the device is 
capable of obtaining recordings lasting up to 20 h.18 
Participants were allowed to go home and carry on with 
their daily activities while wearing the monitor. They were 
advised to turn off and remove the monitor after 20 h of 
use. However, they were at liberty to take off the monitor 
at any time if they experienced any discomfort. The moni-
tor was either collected from patient’s home by the research 
team or returned by the patient following the monitoring 
session. The fetal electrophysiological data recorded 
within the monitor were downloaded via a USB connec-
tion. All the data were analyzed when the study was com-
pleted, to ensure consistency in the analysis.
Questionnaire
Maternal experience for outpatient fetal monitoring was 
evaluated using a self-completed flexible data collection 
questionnaire.19 Participants who demonstrated interest in 
wearing the monitor again were contacted 2 weeks later 
and recruited for the second part of the study. The 2-week 
interval between monitoring sessions was designed to 
study gestational age-related changes in the FHR pattern. 
Similar instructions were given and participants were 
requested to fill in a questionnaire for the second time as 
well. The questionnaire explored the acceptability of wear-
ing the monitor and any associated issues, such as the com-
fort of the device, if their sleep was affected, if it irritated 
their skin and if they were willing to wear the device again. 
These parameters were assessed on a scale of 1 to 10; 
where 1 represented the best outcome and 10 the worst 
(see appendix 1). There was also free text available for fur-
ther explanation of the scores given, and this descriptive 
data were summarized.
To allow an in-depth understanding of the participants 
experience using the monitor and to enhance recruitment 
Figure 1. Monica AN24 device.
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to the main study through understanding women’s percep-
tion of the acceptability of wearing the monitor, that is, 
their motivations or reluctance to wearing the monitor, a 
focus group was conducted. Focus groups can serve a use-
ful function by setting data in context during the explora-
tory phase of a project.20 This method is particularly useful 
for exploring people’s experiences, examining not only 
what they think but how they think and why they think that 
way.21 In addition, they can also enable participants to 
bring forward issues of significance to them.20 In this 
study, the focus group was conducted to provide women 
with an opportunity to discuss their experience of wearing 
the monitor twice at different stages of pregnancy or their 
reasons for declining to do so after wearing it once.
The optimum number of participants for a focus group 
is between 6 and 10, which is large enough to encourage 
discussion, but not too large to inhibit less vocal partici-
pants.22 To achieve the target number of participants for 
the focus group, we contacted 18 women by telephone, of 
whom nine had worn the monitor on two occasions and 
nine had declined to wear the monitor on a second occa-
sion. Written informed consent was obtained from partici-
pants, a loose discussion guide was formulated and a 
guideline for the conduct of focus group and the mainte-
nance of confidentiality was distributed for agreement 
before the discussion began.
The focus group addressed the following research 
questions:
x What are women’s experiences of using the 
monitor?
x What motivates women to wear the monitor?
x Why do women decline a second use of the monitor 
after the first use?
The focus group was audio recorded and later tran-
scribed verbatim. Analysis was conducted using content 
analysis,19 in which the research team independently read 
the transcripts before coming together to discuss their find-
ings. The team searched for common patterns and themes 
emerging from the experiences of the women and their 
relative importance. Opposing views and areas of diversity 
were also considered. Emergent themes obtained by this 
process were explored by two researchers (H.K. and 
E.R.D.) independently and refined until final themes were 
agreed by both researchers as reflective of the data.
Results
The baseline characteristics of the participants and their 
fetuses are given in Table 1.
In total, 59 questionnaires were completed; 35 after 
wearing the monitor for the first time and an additional 24 
from the women who wore the device for a second time. 
The quantitative results are summarized in Table 2.
Of the 18 women contacted for the focus group, 12 
demonstrated interest; however, only six attended the 
meeting. Participants, who attended the meeting, wore the 
monitor on two occasions except for one woman who wore 
it twice but only during the day time. None of the partici-
pants who declined wearing the monitor second time, 
attended for the focus group meeting.
From the analysis, the principal theme identified related 
to the practicality of the fetal ECG device compared to 
Table 1. Maternal demographics, recording variables and delivery data.
Variables Number of patients = 35
Age (years) 28.9 (5.6)
Body mass index, (kg/m2) 23.6 (5.7)
Ethnicity, n (%) White British: 29 (82.9)
Asian: 4 (11.4)
Non-British European: 1 (2.9)
Mixed ethnic group: 1 (2.9)
Parity, n (%) Nulliparity: 14 (40)
Multiparous: 21 (60)
Smoker, n (%) Yes: 12 (34.3) No: 23 (65.7)
Gestational age at recording, (weeks) 33.8 (3.37)
Gestational age at birth, (weeks) 38.4 (1.81)
Onset of labor, n (%) Spontaneous: 10 (28.6)
Induced: 17 (48.6)
Did not labor: 8 (22.9)
Mode of delivery, n (%) Vaginal birth: 23 (65.7)
Cesarean section: 12 (34.3)
Gender of baby, n (%) Male: 14 (40)
Female: 21 (60)
Birth weight (g) 2441.0 (2.81)
The central tendency has been summarized using mean and standard deviation (SD).
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CTG. Other themes identified were: the discomfort that 
resulted from wearing the monitor and the reassurance 
provided in knowing that the baby’s heart rate was being 
monitored. Overall, women concluded that the potential 
advantage of wearing the device outweighed the slight dis-
comfort associated with its use. Direct quotations are used 
to contextualize the women’s views and illustrate themes 
identified from the focus group discussions.
Practicality of the device
All six women described their perceived benefits of being 
able to be monitored at home rather than at the hospital:
It was a million times better; it’s just nice to be able to get on 
with your everyday tasks. I went to work wearing it, and the 
children who I work with only noticed it towards the end of 
the day. (Patient C)
It is absolutely brilliant, after being strapped to a bed for six 
hours during my labour I needed to move around, so I do 
think it will benefit people massively. (Patient E)
I would have much preferred mobile monitoring. When you 
have two small kids, coming to the hospital and getting parked 
for an hour of monitoring is a lot of hassle, especially if you 
have to do it on a regular basis, which you do when you have 
a small baby. (Patient F)
Patient E further explained why she thought the mobile 
monitoring would be beneficial and how it would provide 
reassurance to the parents:
I think it is nice that it will be monitoring you doing your 
everyday activities rather than just being sat down. When you 
are monitored in hospital it is only getting a recording of what 
the baby’s heart is doing then. However, I still took the dogs 
for a walk during pregnancy, so if that affected the heart rate 
of the baby then this new monitor would tell you and would 
reassure you that it is safe to be active during pregnancy. 
(Patient E)
Before taking part in the study, some women were con-
cerned that the device might interfere with daily activities 
and prevent them from getting on with jobs. However, 
women at the focus group concluded that, for the majority 
of the time, the device was barely noticeable:
It was only really apparent when getting dressed and 
undressed, as I obviously had to reposition the device. 
(Patient D)
It did not prevent me from doing anything, in fact, I am sure I 
could have gone to the gym wearing it, or gone for a run! 
(Patient A)
Before it started itching I totally forgot about it, however, I am 
very sensitive to plasters and so when it started itching that 
was all I could think about and so had to remove it. (Patient E)
There were some concerns about the design of the 
device and opinions were divided. Some women felt that 
the wires from the monitor to the electrode pads were too 
long:
When going to the toilet you had to tuck all the wires back in, 
and there seemed to be quite a lot of excess. (Patient B)
As I only had the device on during the day, and so kept it 
around my neck, I did not need the wires to be as long as they 
were, it made it quite cumbersome. (Patient E)
I kept getting tangles in the wires because they were too long! 
(Patient C)
However, Patient A felt that the wires were not long 
enough:
The wires could have done with being a tiny bit longer. When 
laid in bed where do you put it? If you have a long top on then 
the leads have to go down the bottom and back up to the 
pillow, and this left little room for movement. (Patient A)
It appeared that there was a need for longer wires at 
night to allow movement when changing positions. 
However, during the day, the excess wires got in the way. 
Nonetheless, the discussion group did provide valuable 
feedback as to how other aspects of the device could be 
improved to make it more practical. For example, patients 
were given the option of wearing the device around their 
neck using the lanyard or putting it in a pocket. Some 
women found it heavy to wear round their neck for the 
whole day, but at the same time were nervous about put-
ting it in their pockets, in case they accidentally pressed a 
button and interfered with the monitoring. It was suggested 
that a clip on the back of the device would be beneficial so 
that it could be attached to clothing to secure it. In addi-
tion, respondents felt that a clear case covering the monitor 
would prevent patients from accidentally pressing the 
buttons.
Discomfort caused by the device
The experience of wearing the device varied according to 
each individual, and this was particularly noticeable when 
the women were asked how wearing the device affected 
Table 2. Summary of questionnaire results.
Questionnaire results Result*
Q1. How comfortable was the monitor? 3 (2–6)
Q2. Did wearing the monitor disturb your sleep? 2 (1–4)
Q3. Were you affected by a rash or marks on 
the skin under or around the sticky pads?
2 (1–6)
* Scores from 1 (best) to 10 (worst), with results displayed as median 
and interquartile range (IQR).
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their sleep. Some found that they barely noticed it, others 
found it so irritating that they had to remove it:
At night I would go to turn over having forgotten I was 
wearing the device and then I would feel something tug which 
reminded me that I had to move the device as well. (Patient B)
I didn’t wear the device at night, I just wore it through the day 
as it caused me too much irritation. (Patient E)
I had a small bump and usually would sleep on my front as 
this was most comfortable, however, when wearing the 
monitor I was unable to do this and so it made it more difficult 
to get to sleep. (Patient A)
One of the major concerns of the device was the irrita-
tion that the electrode pads caused. Two women said that it 
was itchy to wear. Patient F explained why she felt itchy:
During pregnancy your belly contracts and expands, and so 
when the device was fitted it is loose, but then your belly goes 
really tight, and that is when you notice it and it starts to itch 
as the skin is stretched. (Patient F)
Patient C did not find the device irritating to wear, she 
said,
It did not cause any irritation while wearing the device; 
however, when I removed the pads the skin was a bit itchy 
where they had been and there was a slight redness, but this 
did not last very long at all. (Patient C)
The extent to which marks were left on the patients’ skin 
varied. Patient E, who is sensitive to plasters, said it took a 
few days for the marks to fade completely after removing 
the device, whereas Patient D said it only took a few hours.
Reassurance provided by the monitoring
Ultimately the women felt that if wearing the monitor ben-
efited their babies, then it was worth the slight discomfort:
The more that can be done to make sure you have a healthy 
baby at the end, the better. I think most mothers would do 
whatever needed doing to make sure the outcome is good. It 
does not matter if you have to wear a few wires for a week, or 
even for the whole pregnancy. (Patient A)
If it is helpful for your baby then you keep it on, but it was a 
relief to take it off. (Patient F)
Ultimately the positives of wearing it completely outweigh 
the negatives, knowing you are giving vital information is 
worth a little bit of discomfort. (Patient E)
The women were aware that their baby would not 
directly benefit from this study. However, during the focus 
group, it was explained to them that if the device was 
approved for wider use then the information would be 
relayed to the hospital in real-time to be reviewed by staff. 
The women liked this concept and felt it would provide 
reassurance:
It would make me feel safer because if something was wrong 
the hospital staff would be straight on the phone to you. 
(Patient B)
It would be reassuring to know that someone is checking the 
heart rate, as long as technology works that is. (Patient D)
However Patient E also commented that wearing the 
device made her partner anxious:
My partner had more questions than I did, and at one point he 
said that seeing me wearing the device reminded him that 
there could be a problem. (Patient E)
When asked how they felt about being able to view 
feedback about their baby’s heart rate directly via an appli-
cation on their phone they were less approving:
I think only tell patients information on a need-to-know basis. 
The way you feel affects your pregnancy, and so you would 
not want to cause someone to feel more anxious than 
necessary. Even if your baby was not small, pregnancy is still 
a scary time as you do not know what is happening. No matter 
if it is a high or low risk pregnancy, less information is better. 
(Patient C)
I quite like the idea that the heart rate was being monitored and 
professional people were going to analyse it. If I could look at 
it I would be constantly wanting positive feedback, and if it 
was not there it could cause more anxiety than necessary. I 
think you can be given too much information sometimes but 
less can be better. Women with small babies are already 
anxious, and there is no need to add more. (Patient A)
Discussion
We report for the first time that the fetal ECG monitor is 
an acceptable method of long-term FHR monitoring even 
when repeat monitoring is required during the same 
pregnancy.
Rauf et al.13 assessed maternal views on telemetric fetal 
ECG monitoring in 51 women undergoing induction of 
labor at home using semi-structured diaries as well as a 
4-point scales. The device was worn for a median time of 
10 h and was acceptable to 46 out of 51 women (90%).
Comparing the results from our study to Rauf et al.,13 
there may be alternative reasons to why 31.4% patients did 
not wear the monitoring device for the second time. In the 
home induction of labor study,13 women were directly ben-
efiting from taking part in the research study and as a 
result, there was an incentive to participate in the future. 
However, in our study, the women were not informed of 
6 Women’s Health 
the results of the FHR monitoring, and hence there was no 
incentive to wear the device again. Nevertheless, two-
thirds of participants wore the monitor twice and com-
pleted the study, suggesting that the fetal ECG monitor is 
an acceptable method of long-term outpatient monitoring 
for SGA fetuses.
The quantitative data on a scale of 1 to 10 for the 59 
completed questionnaires illustrated an average comfort 
level of three, sleep disturbance of two and rash severity of 
two. Given that numerical values are subject to personal 
interpretation and consequently are likely to be arbitrary, 
participants were asked to provide explanations for their 
numerical score after each scale. Such free-text annota-
tions added richly to the quantitative data19 and, in this 
study, enabled a better interpretation of the numerical 
scores provided regarding the comfort of the monitoring 
device.
The most common comment in an additional free-text 
space on the questionnaire was the report of itching, which 
occurred as a result of the electrode pads on the abdomen. 
Our study used Ambu electrodes, as recommended in a 
previous study23 which determined signal-to-noise ratio 
and compared the success rate of FHR recording using 
three different types of electrodes (Ambu, Covidien and 
Red dot). That study concluded that the success rate of 
acquiring FHR signals were higher with Ambu and 
Covidien compared to the Red dot. However, the study did 
not determine the degree of discomfort of irritation associ-
ated with either electrode pad. We employed the Ambu 
electrodes, as these had received regulatory approval (the 
CE Mark) in the United Kingdom. Further investigation is 
required to determine which of the electrodes was associ-
ated with the least irritation such as itching.
Women also commented on the practicality of wearing 
the device. While some found the device heavy to wear 
around the neck, others commented that the wires were too 
long and therefore made it impractical to wear. Suggestions 
as to how this could be improved included the addition of 
an elasticated belt or clip on the device to enable it to be 
better secured. There was a need for the device to be fixed 
during the day to prevent it disturbing daily activities and 
for it to be placed under the pillow at night to prevent it 
disturbing sleep.
The final question in the questionnaire asked patients to 
explain why they were, or were not, willing to wear the 
monitoring device again. Experiences varied and opinions 
were divided as a result. Some patients hardly noticed the 
device once they got used to wearing it; however, others 
found it very uncomfortable to wear. Despite this, overall, 
participants felt that if medically indicated, they would 
wear the monitoring device for the benefit of their babies.
Results from the focus group complimented those from 
the questionnaire. However, in the focus group, it was pos-
sible to obtain more detailed feedback on different aspects 
of wearing the device. Although, our focus group was 
limited by the fact that none of the participant who declined 
wearing the monitor second time attended; it was impres-
sive to hear both positives and negative comments from the 
ones who wore the monitor twice and attended the meeting. 
Nonetheless, the results should be interpreted with caution 
as the focus group comprised of women who wore the 
device on two occasion implying that they had a positive 
perception of fetal ECG monitoring in the home setting.
To our knowledge, no other focus groups have been 
conducted to learn more about the experience of wearing 
the fetal ECG–monitoring device (Monica AN24) during 
pregnancy. A qualitative study using semi-structured indi-
vidual interviews on 15 women who participated in the 
trial of home induction of labor using the Monica AN24 
device demonstrated willingness to undertake the same 
experience again if invited to do so for induction of labor 
in future pregnancies.14 The analysis identified three main 
themes based on the women’s feedback: “the need for 
women to labor within their comfort zone,” “a desire to 
achieve the next best thing to a normal labor” and “the 
importance of a virtual presence to offer remote reassur-
ance.”14 Similarly, participants in our study commented on 
the practicality of being able to wear the device at home. 
They felt it was beneficial to be monitored in their comfort 
zone in order to obtain a realistic recording of how the 
baby responded to daily activities. They also commented 
on the reassurance provided in knowing that their baby 
was being monitored and that someone else would be 
viewing the results. All participants in the focus group felt 
that despite the discomfort caused by the monitoring 
device, they would be willing to wear the device again for 
the benefit of their unborn child.
A further limitation is related to an informal assessment 
of maternal anxiety. We did not use validated question-
naire which raises a question on the reliability of results 
and limits the generalization of findings. However, a recent 
systematic review of maternal anxiety scores in preg-
nancy24 has demonstrated that none of these are completely 
reliable, and therefore, the use of these would not have sig-
nificantly affected the reliability of the results obtained.
Practical limitations of the device predominantly 
focused on the number of cables. Although, manufacturers 
of Monica AN24 appear to be responding to these con-
cerns, as the most recent model of Monica AN24, the 
Monica Novii, has a cable-free design.25 Suggestions made 
by the study participants can help manufacturers in further 
refining the design of the monitoring device.
Conclusion
In conclusion, we have shown that women would consider 
ambulatory FHR monitoring at home when indicated. 
Overall, the study approved the concept of long-term home 
monitoring, identified the portable fetal ECG monitor as a 
promising method of monitoring SGA fetuses and has 
Kapaya et al. 7
highlighted the facilitators and barriers to wearing the 
monitor in clinical care or research. These observations 
can be used to undertake robust research to assess the use 
of the portable fetal ECG monitor for optimizing the tim-
ing of delivery for SGA fetuses to prevent stillbirth.
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Appendix 1
Questionnaire
Q1a)  How comfortable was the monitor? Please rate comfort from 1 to 10, where 1 means the monitor was extremely 
comfortable and 10 means it was extremely uncomfortable.
Level of comfort
1 2 3 4 5 6 7 8 9 10
 
Q1b) If you found wearing the monitor uncomfortable in any way, please explain why?
Q2a)  Did wearing the monitor disturb your sleep? Please rate disturbance from 1 to 10, where 1 means your sleep 
was not disturbed at all and 10 means the monitor made it extremely difficult to sleep.
Amount of sleep disturbed
1 2 3 4 5 6 7 8 9 10
 
Q2b) If your sleep was disturbed in any way, please explain why?
Q3a)  Were you affected by a rash or marks on the skin under or around the sticky pads? Please rate how you 
were affected from 1 to 10, where 1 means you had no rash or marks and 10 means you were severely affected 
by a rash, marks or both.
Amount of rashes/mark
1 2 3 4 5 6 7 8 9 10
 
Q3b) If you had a rash, marks or both, please describe what happened and how long they lasted?
Q4a) Are you still prepared to wear the monitor for a second 16 hour period?
Yes Not sure No
 
Q4b) Please explain your answer.
Thank you for completing the questionnaire.
